{"ORPHApacket":[{"ORPHApacketID":"94090","date":"2019-12-05 20:01:52","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"94090","Name":[{"lang":"en","label":"Pseudohypoparathyroidism type 2"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_94090","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Pseudohypoparathyroidism without Albright hereditary osteodystrophy"}],"ORPHA":"457062","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_457062"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Pseudohypoparathyroidism type 2 (PHP2) is a type of pseudohypoparathyroidism (PHP; see this term) characterized by resistance to parathyroid hormone (PTH), which manifests with hypocalcemia, hyperphosphatemia and elevated PTH levels, absence of Albright's hereditary osteodystrophy (AHO; see this term), and normal expression of the Gs protein with a normal urinary cAMP response."}],"ExternalReferenceList":[{"count":"1","ExternalReference":[{"Source":"OMIM","Reference":"203330","DisorderMappingRelation":[{"id":"21527","Name":[{"lang":"en","label":"E (exact mapping (the terms and the concepts are equivalent))"}]}]}]}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"All ages"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Not applicable"}]}]}],"HPODisorderAssociationList":[{"count":"16","HPODisorderAssociation":[{"HPOId":"HP:0000852","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000852","HPOTerm":"Pseudohypoparathyroidism","HPOFrequency":[{"ORPHA":"453310","Name":[{"lang":"en","label":"Obligate (100%)"}]}]},{"HPOId":"HP:0002901","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002901","HPOTerm":"Hypocalcemia","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0002905","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002905","HPOTerm":"Hyperphosphatemia","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0003165","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0003165","HPOTerm":"Elevated circulating parathyroid hormone level","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0002199","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002199","HPOTerm":"Hypocalcemic seizures","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0001657","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001657","HPOTerm":"Prolonged QT interval","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0003394","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0003394","HPOTerm":"Muscle cramps","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0003401","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0003401","HPOTerm":"Paresthesia","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0003472","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0003472","HPOTerm":"Hypocalcemic tetany","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0003739","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0003739","HPOTerm":"Myoclonic spasms","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0011458","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0011458","HPOTerm":"Abdominal symptom","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0012049","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0012049","HPOTerm":"Laryngeal dystonia","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0003456","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0003456","HPOTerm":"Low urinary cyclic AMP response to PTH administration","HPOFrequency":[{"ORPHA":"453315","Name":[{"lang":"en","label":"Excluded (0%)"}]}]},{"HPOId":"HP:0003761","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0003761","HPOTerm":"Calcinosis","HPOFrequency":[{"ORPHA":"453315","Name":[{"lang":"en","label":"Excluded (0%)"}]}]},{"HPOId":"HP:0010766","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0010766","HPOTerm":"Ectopic calcification","HPOFrequency":[{"ORPHA":"453315","Name":[{"lang":"en","label":"Excluded (0%)"}]}]},{"HPOId":"HP:0030057","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0030057","HPOTerm":"Autoimmune antibody positivity","HPOFrequency":[{"ORPHA":"453315","Name":[{"lang":"en","label":"Excluded (0%)"}]}]}]}],"HPODisorderSetStatus":[{"ValidationStatus":"y"}]}]}